Loading stock data…
$168.53+4.19 (+2.55%)
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.
ICON Public Limited Company in the Healthcare sector is trading at $168.53 with a market capitalization of $12.6B. Wall Street consensus targets $185.88 (17 analysts), implying a +10.3% move over the next 12 months. The stock is currently 17% below its 52-week high of $203.91, remaining 15.6% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.06B↑ | $2.03B↓ | $2.19B↑ | $2.08B↑ | $2.04B |
| Gross Profit | $479.29M↑ | $477.93M↓ | $500.89M↓ | $545.46M↓ | $583.33M |
| Operating Income | $194.21M↑ | $187.00M↓ | $230.37M↓ | $249.38M↓ | $280.61M |
| Net Income | $72.58M↓ | $104.75M↑ | -$110.14M↑ | -$284.18M↓ | $203.52M |
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management...